Imaging for early stage breast cancer

Conclusion, RAPID 3D CRT APBI given in 1 week increases rates of adverse cosmesis and late RT toxicity compared with standard WBI 3D CRT APBI should not take place outside clinical trial Limitations Short follow up Further studies are needed to identify characteristics in patients who are well treated with 1 week 3D CRT APBI Randomized Trial of Accelerated Partial Breast Irradiation, The RAPID trial Strenghts Randomised This interim analysis reports the most robust data on cosmesis from a 3D CRT APBI trial using 1 week therapy Patients, nurses and doctors reported similar results

Caution: alternative field arrangements using 5 day regimens